started · updated
Medical advancements offer new hope for managing chronic kidney disease
Recent medical research and clinical observations highlight new strategies for managing chronic kidney disease and preventing its progression, particularly in patients with diabetes.
Studies published in the Chinese Journal of Natural Medicines suggest that the plant-derived compound hederagenin, found in ivy and black cumin, may protect kidney health. It reportedly works by activating an anti-aging gene to mitigate kidney senescence caused by diabetes.
In clinical practice, combining different classes of medications is showing success in delaying the need for dialysis. Effective combinations include RAS blockers, SGLT2 inhibitors, mineralocorticoid receptor antagonists, and GLP-1 receptor agonists. These treatments target blood pressure, glucose metabolism, and inflammatory processes to stabilize organ function. However, research also notes risks, such as ketoacidosis associated with SGLT2 inhibitors in type 2 diabetes patients, as observed in Scandinavian cohorts published in The Lancet Diabetes & Endocrinology.
Entities
Chinese Journal of Natural Medicines · The Lancet Diabetes & Endocrinology